WAVE Life Sciences Ltd

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 57.08, 57.87, 122.89, 250.56, 584.1 ], "ebit_estimate": [ -234.4, -286.32, -281.99, -212.42, 4.41 ], "ebitda_estimate": [ -200.66, -283.5, -295.13, null, null ], "net_income_estimate": [ -222.07, -253.15, -267, -212.02, 0.12 ], "per_share_eps_estimate": [ -0.91, -1.19, -1.14, -0.85, 0.24 ], "eps_nri_estimate": [ -1.1, -1.21, -1.12, -0.81, 0.18 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 0.24, 3.17, null, null, null ], "pretax_income_estimate": [ -175.94, -242.22, -247.29, -229.24, 8.29 ], "operating_cash_flow_per_share_estimate": [ -0.85, -1.31, null, null, null ], "roa_estimate": [ -34.7, -36.1, null, null, null ], "roe_estimate": [ -41.35, -114.54, -237, null, null ], "gross_margin_estimate": [ 50, 91.75, 91.5, 91.25, 90 ], "operating_cash_flow_estimate": [ -170.14, -262.22, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 25.87 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "37.48", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 37.48, "future_ebit_estimate_growth": -10.61, "future_ebitda_estimate_growth": -14.33, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -9.78, "future_pretax_income_estimate_growth": -9.32, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -70.55, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 7.05, 6.84, 7.67, 0.25, null, 3.77, 8.23 ], "ebit_estimate": [ -63.76, -66.37, -70.56, -74.2, -76.7, -74.45, -77.95 ], "ebitda_estimate": [ -58.07, -56.73, -55.41, null, null, null, null ], "net_income_estimate": [ -61.32, -63.5, -66.38, -73.2, -76.2, -73.95, 72.55 ], "per_share_eps_estimate": [ -0.31, -0.32, -0.14, -0.38, -0.39, -0.39, 0.09 ], "eps_nri_estimate": [ -0.31, -0.32, -0.34, -0.38, -0.39, -0.39, 0.09 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 0.41, 0.17, 0.45, null, null, null, null ], "pretax_income_estimate": [ -61.38, -63.32, -22.83, -73.2, -76.2, -73.95, 72.55 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -44.02, -47.82, -52.31, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "37.48", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 37.48, "future_ebit_estimate_growth": -10.61, "future_ebitda_estimate_growth": -14.33, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -9.78, "future_pretax_income_estimate_growth": -9.32, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -70.55, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }